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Objectives/Hypothesis: To describe the clinical experience and characterize the outcomes of cochlear implantation (CI)
in children with isolated enlarged vestibular aqueduct (IEVA) as compared to children with enlarged vestibular aqueduct
(EVA) associated with other bony labyrinth abnormalities.
Study Design: Single, tertiary care, institutional retrospective review over 2 decades.
Methods: The clinical course and outcomes of 55 children with EVA undergoing CI between 1991 and 2013 were
reviewed. Test measures included open and closed set speech perception tests, and various speech and language measures.
Results: In 18 children (32.7%), IEVA was the only defect present. In 33 children (60%), EVA occurred concomitantly
with incomplete partition type 2 (IP 2) bilaterally, and three children with incomplete partition type 1 bilaterally. Ninety-two
percent (51 of 55) occurred bilaterally and had matching bony defects. Mean age of CI was 73.4 months. A statistically signif-
icant defect-related and linguistic-status pattern was noted, impacting the timing of implantation: IEVA5 112.8 months, IP
25 58.4 months (P<.001), prelingual deafness5 53.8 months, postlingual deafness5 110.8 months (P<.001). Controlling for
implant age and hearing loss severity, IEVA children demonstrated superior performance on speech perception tests (8.2 to
20.3 point differences), though statistical significance was inconsistent (P5.01–.40. Performance was also superior in speech
and language tests, though statistical significance was never reached (2.9–13.9 point differences; P5.14–.69).
Conclusions: Children with hearing loss secondary to EVA respond meaningfully to cochlear implantation. However, the
severity of temporal bone anomalies in these children has clinical relevance.
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INTRODUCTION
An enlarged vestibular aqueduct (EVA) continues to
be the most common radiographic abnormality apparent
on temporal bone imaging studies of patients with con-
genital sensorineural hearing loss.1 Nearly 20 years
have passed since the first report of cochlear implanta-
tion (CI) in patients with an EVA.2 Since that time, the
EVA syndrome itself has been better characterized. Orig-
inally emphasized for its progressive sensorineural hear-
ing loss, it is now understood that it can encompass a
heterogeneous course.1,3–7 Conductive components
resulting in mixed losses may be identified, and the sen-
sory component may be stable or fluctuating.1,5,8,9 Ves-
tibular complaints are not uncommon.7,8,10 At least one
known genetic cause has been discovered causing EVA,
although the condition can be associated with syndromic
or nonsyndromic hearing loss.11,12 Standardized proto-
cols to reproducibly determine vestibular aqueduct size
on temporal bone computed tomography (CT) have been
developed.6,13 It is clear that EVA can exist in isolation
or be accompanied by various temporal bone abnormal-
ities (i.e., incomplete partition. It is largely accepted that
EVA itself is not the causative factor of the hearing loss,
but rather functions as a marker of an underlying
abnormality, itself likely responsible for the hearing
loss.7
In a similar manner, our understanding of the sur-
gical management of EVA syndrome and the subsequent
clinical outcomes has grown considerably. For example,
surgical interventions to arrest hearing deterioration
such as endolymphatic sac surgery have proven unsuc-
cessful,4,14 but CI for children meeting criteria has
become the treatment of choice. Over time, surgical
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concerns such as perilymphatic “gushers,” persisting cer-
ebrospinal fluid leak, incomplete electrode insertion, and
postoperative meningitis have been reported in a minor-
ity of patients.15 The child with EVA in isolation is
expected to achieve postimplantation speech perception
outcomes comparable to those of children with normal
temporal bone anatomy.16,17 Even individuals with coex-
istent cochleovestibular abnormalities accompanying the
EVA will generally have favorable postimplantation
speech perception outcomes, although this is often
dependent on the severity of the temporal bone
deformity.15,16,18
Early implantation in children with congenital deaf-
ness is highly advantageous.19,20 Children are being
implanted within the first year of their life.21 Despite
the growing body of knowledge, ascertaining the best
time for surgical intervention in the postlingually deaf
child has been elusive.22 Substantial effort is invested in
routinely following these children to intervene at the
ideal time—when the hearing provided by a cochlear
implant will reliably exceed that provided by amplifica-
tion. Yet little information exists on speech and language
outcomes of pediatric recipients of CI with EVA. A recent
systematic review on cochlear implantation in children
with cochleovestibular anomalies made no mention of
postimplantation language skills.15
The University of Michigan has been performing
CIs since 1984, and to date has performed more than
2,200 implant surgeries. Approximately 40% of the recip-
ients have been children. This study details the experi-
ence over the past 2 decades of treating pediatric
EVA CI recipients. Residual hearing, speech recognition,
and speech/language skills of children with EVA who
received a cochlear implant were systematically
reviewed. Comparative analysis between children with
isolated EVA (IEVA) and children with EVA accompanied
by other bony labyrinth abnormalities was performed.
MATERIALS AND METHODS
University of Michigan Institutional Review Board
approval was obtained for this project. Using medical records
and a cochlear implant database, individuals who were 18 years
of age or younger at time of EVA diagnosis and subsequently
underwent CI during the years 1991 to 2013 were identified.
The two neuroradiologist authors reviewed available CT tempo-
ral bone scans, and EVA diagnosis was confirmed by consensus.
When images were unavailable for review, diagnosis was based
upon careful review of radiology reports and otologist statements
in the patient’s medical record. In this study, the Cincinnati cri-
teria for EVA was used; vestibular aqueducts measuring >2 mm
at the operculum or >1 mm at the midpoint on axial CT were
categorized as enlarged.6 Established criteria for classification of
congenital inner ear malformation were applied.23 Incomplete
partition type 2 (IP 2) consists of vestibular dilation and only 1.5
turns of the cochlea accompanying the EVA. Incomplete partition
type 1 (IP 1) is characterized by a cystic cochlea with an absent
modiolus and a dilated vestibule. Cochlear implantation candi-
dacy was determined by measures that included pure-tone audi-
ometry, speech perception and speech and language assessment,
clinical exam, and radiographic imaging (i.e., CT).
Demographic data obtained included gender, age of
implantation, age of activation, side of implantation, presence of
a contralateral implant, implant type and quality of insertion.
For sequential implants, data for the first implanted ear were
recorded. A postimplantation communication method was noted
and classified as auditory alone versus total communication; the
former included children who utilized auditory–verbal or audi-
tory–oral communication, whereas the latter included children
who used any form of sign language (either alone or in combina-
tion with an oral mode of communication). Air and bone conduc-
tion thresholds were obtained using pure-tone audiometry. The
most recent audiogram obtained prior to CI was used in data
analyses. Pure-tone averages (PTAs) were calculated for each
ear separately and were represented as the average threshold
of 500 Hz, 1,000 Hz, 2,000 Hz, and 3,000 Hz. A “no response” at
maximal testing for a particular frequency was categorically
assigned a value of 125 dB.
Pre- and postoperative speech perception testing was
achieved using four open-set tests: the Glendonald Auditory-
Screening Procedure Sentences (GASP Sentences), the Glendo-
nald Auditory-Screening Procedure Words (GASP Words),24 the
Lexical Neighborhood Test and the Multisyllabic Lexical Neigh-
borhood Test,25 and two closed set tests: the Word Intelligibility
by Picture Identification test26 and the Northwestern Univer-
sity–Children’s Perception of Speech27 test. Pre- and postopera-
tive speech and language skills were assessed using three
subtests of the Woodcock-Johnson (WJ) diagnostic battery28:
Oral Comprehension, Passage Comprehension (WJPC), and
Understanding Directions. Additionally, the Peabody Picture
Vocabulary test,29 which examines receptive vocabulary, and
the Expressive Vocabulary Test,30 which evaluates expressive
vocabulary, were also administered. Standardized scoring is
used for all of the speech and language measures; a score fall-
ing between 85 and 115 is considered within normal range. The
resulting data were organized into the following clustered post-
operative increments: 6 months (3–9 months), 12 months (9–18
months),and 24 months (18–30 months). All available data were
used. Patients with cognitive impairment or inconsistent users
of their CI were excluded.
Statistical analysis was performed using available soft-
ware. A two-sided Student t test was used on continuous level
data; v2 analysis was performed on categorical level data. Lin-
ear models fit using generalized estimating equations (GEEs)
were used to assess the relationships between predictors (defect
type, age at implant, severity of hearing loss, and postoperative
interval) and outcomes (various speech and language tests). Age
at implantation was dichotomized to <5 years and 5 years of
age. Hearing loss severity was classified as severe (70–90 dB) or
profound (>90 dB) in the better hearing ear. GEE accounts for
the dependency between repeated measures taken on individual
subjects and was applied using compound symmetric within-
subject covariance. Mean structures were defined in terms of
main effects for the three predictors of interest. No formal
adjustments for multiple comparisons were performed, so signif-
icance levels were interpreted conservatively.
RESULTS
Demographics
Fifty-seven patients with a diagnosis of EVA under-
went cochlear implantation from 1991 to 2013. Two
patients were excluded, as coexistent reasons for congen-
ital deafness could not be excluded (Connexin 26 with
homozygous 35delG defects for one patient and congeni-
tal cytomegalovirus in the other). Demographic informa-
tion for the remaining 55 individuals is provided
Table I). Fifty-one of 55 subjects demonstrated
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symmetrically matched temporal bone anatomy. Three
patients had unilateral EVA with normal contralateral
temporal bone anatomy, and one patient had an IP 2 of
the right ear and IP 1 of the left ear. There were no stat-
istically significant differences in the distribution of chil-
dren when comparing various combinations of radiologic
defect, degree of residual hearing, or communication cat-
egories as detailed in Table II. Implantation characteris-
tics of the recipients including laterality and device type
are provided in Table III.
Audiometric Outcomes
Preoperative audiograms were available for 51 chil-
dren. No significant difference existed in the preopera-
tive mean PTAs for the right and left ears of the group
collectively (P5.26). However, ears with more complex
temporal bone defects demonstrated greater hearing loss
(higher PTAs) at the time of surgery (P5.03). The mean
age at implantation for children with IEVA was 112.8
months; the mean of children with IP 2 anatomy was
58.4 months (P<.001). The small number of patients
with IP 1 and the large range in age at implantation
make meaningful interpretation difficult for this group.
The PTA at time of implantation, grouped by decade,
was also explored. A trend toward implantation with
more residual hearing was noted with each progressive
TABLE I.
Demographics of Patients With EVA Undergoing Cochlear
Implantation.
SD P Value
Total patients 55
Male 27
Female 28
Bilateral 52
Unilateral 3 [right52; left 51]*
EVA alone (total) 18
Available 15
IP 2 34†
Available 33
IP 1 3†
Available 2
Immediate preoperative PTA (range)
Right 103.3 (71–121.5) 13.55 .26
Left 100.2 (68–125)‡ 14.09
EVA alone 98.7 (77–111) 11.42 .03
IP 2 105.2 (71–125) 13.71
IP 1 109.1
Defect type preoperative PTA (range)
EVA right, n5 13 98.8 (77–113.1) 10.28 .94
EVA left, n5 13 98.6 (68–115) 12.82
IP 2 right, n5 27 107.6 (71–125)* 13.67 .10
IP 2 left, n527 102.8 (72–125)* 13.56
IP 1 right, n5 2 112.5 (110–115)
IP 1 left, n52 110.1 (108–112)
Age implantation, mean age, mo
Overall mean 73.4 53.23
EVA, n5 13 112.8 57.42 <.001
IP 2, n529 58.4 44.1
IP 1, n52 74
Severe (dB <90) 67.9 37.06 .47
Profound (dB >90) 80.2 58.8
Auditory only 75 52.97 .92
Combined communication 76.9 56.99
Postimplant communication method, total no
Auditory only 30
Combined 12
*Three patients with EVA only and normal contralateral temporal
bones.
†Note: one patient with IP 1 and IP 2.
‡Used to denote limit of audiometry with no response.
EVA5 enlarged vestibular aqueduct; IP5 incomplete partition;
PTA5pure-tone average; SD5 standard deviation.
TABLE II.
Classifying Characteristics of Children With Enlarged Vestibular
Aqueduct Undergoing Cochlear Implantation.
No. P Value
Defect type vs residual hearing .72
EVA1 severe 4
EVA1profound 10
IP 21 severe 7
IP 21profound 23
Communication method vs. residual hearing .46
Auditory1 severe 9
Auditory1profound 19
Total1 severe 2
Total1profound 9
EVA5 enlarged vestibular aqueduct; IP5 incomplete partition;
TABLE III.
Implantation Characteristics of Enlarged Vestibular Aqueduct
Recipients.
Total implants 55
Implant type
(CI22M) Nucleus 22 7
(CI24M) Nucleus 24M 9
(CI24R) Nucleus 24 contour 13
(CI24RE) Nucleus Freedom contour advance 13
(CI 500 series) Nucleus CI 512 4
Advanced Bionics HiRes 90K 2
Advanced Bionics Clarion 5
Med-El Combi 406 2
Implant laterality
Right 37
Left 18
Subsequent contralateral (or bilateral) 9
Insertion
Device failure, reimplant 6
Full 52
Partial 1
Unknown 2
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decade (see Supporting Figure 1 in the online version of
this article).
Speech Perception
Speech perception data were available for 42 chil-
dren; 16 with IEVA (10 profound and six severe hearing
loss), and 26 with IP 2 (20 profound and six severe) (see
Supporting Figure 2A,B in the online version of this
article, which demonstrate the clinical course for all sub-
jects [mean scores are shown]). Statistically significant
improvement over the baseline (P<.001–.05) was
achieved. Children in both categories demonstrated the
steepest slope in hearing recovery during the first 6
months following implantation, but continued to improve
or remained stable during the study period. The excep-
tion to this trend in the separated groups appeared in
the IEVA category, where a decline in GASP word and
sentence testing was noted at the 2-year mark. Dataset
analysis in this case suggested this was a function of the
small number of individuals in this category at this
interval, and marginal performance in one of three indi-
viduals affected the mean considerably.
Language
Speech and language data for 41 children were
available for analysis; 14 with IEVA (eight profound and
six severe), and 27 with IP 2 (20 profound, five severe,
two unclassified). Mean postimplant scores were similar,
remaining stable or slightly improving over baseline (for
results see Supporting Figure 3A,B in the online version
of this article).
Model
Depending on the assessment tool, scores for 15 to
30 children (speech perception) and 12 to 34 children
(speech and language) were included in the regression
model. IEVA children consistently outperformed their IP
2 counterparts in speech perception tests. Controlling for
age and severity of hearing loss at implantation, there
was an 8 to 20-point difference between the groups,
though statistically significant in less than half (Table
IV). A similar performance discrepancy was seen in
speech and language assessment, although this differ-
ence was not statistically significant. (The exception in
WJPC was attributed to the insufficient sample size.) A
non–statistically significant advantage was noted in chil-
dren with severe losses, compared to profound loss of
varying magnitudes in both types of tests. P5.05 in the
GASP Word testing. Older children demonstrated a
meaningful performance advantage in two of the open-
set tests (GASP Sentence and Word: 26.9, P<.01; and
20.3, P5.02, respectively), after controlling for defect
type and severity of hearing loss.
DISCUSSION
The enlarged vestibular aqueduct syndrome is a fre-
quent cause for sensorineural hearing loss in early child-
hood. However, children with an EVA are a
heterogeneous group. Existing literature demonstrates
TABLE IV.
Pediatric EVA Cochlear Implantation Regression Model*
Defect Type, IP 2 vs. EVA Age at Implant, >5 Years vs. <5 Years Severity of Loss, Profound vs. Severe
Point
Difference P Value 95% CI
Point
Difference P Value 95% CI
Point
Difference P Value 95% CI
Speech perception
GASP sentence 220,3 .03† 239.2 to 21.4 26.9 <.01† 9.1 to 44.6 12 .2 29.2 to 5.3
GASP word 211.9 .22 231.3 to 7.6 2.3 .02† 2.5 to 38.1 213.5 .05† 227.8 to20.01
LNT 211.8 .16 228.5 to 4.8 29.5 .42 233.1 to 14.1 22.7 .73 218.5 to 13.0
MLNT 29.2 .4 231.1 to12.7 20.1 1 223.6 to 23.4 210 .22 226.3 to 6.24
NU-CHIPS 28.2 .27 222.9 to 6.5 3 .67 210.9 to 16.9 20.9 .89 213.9 to 12.1
WIPI 216.6 .01† 226.5 to 26.8 24.4 .52 218.0 to 9.2 26.3 .34 219.7 to 7.0
Speech and language
PPVT 23 .68 8.4 .21 25.0 to 21.7 6.9 .03† 38.8 to 99.7
WJOC 210 .46 215.7 .22 241.2 to 9.7 20.2 .23 213.3 to 53.7
WJPC 3.3 .22 210.6 .58 249.3 to 28.1 22.8 .56 212.5 to 6.8
WJUD 28.9 .48 24.3 .7 227.0 to 218.3 27.4 .11 27.1 to 61.9
EVT 213.4 .16 0.15 .99 216.6 to 16.9 8.4 <.01† 2.2 to 14.7
*Differences in mean speech perception and mean speech/language scores are provided for comparisons made between the following groups: 1) defect
type (EVA vs. IP 2), 2) age at implant (children implanted >5 years of age versus <5 years of age, and 3) severity of loss (children with severe losses vs chil-
dren with profound losses). Negative point value differences reflect a higher mean score by the second group. Values reflect points in score and are adjusted
for postimplantation status. Significant differences between the two groups are compared.
†P.05.
CI5 confidence interval; EVA5 enlarged vestibular aqueduct; EVT5Expressive Vocabulary Test; GASP5Glendonald Auditory Screening Procedure;
IP5 incomplete partition; LNT5 Lexical Neighborhood Test; MLNT5Multisyllabic Lexical Neighborhood Test; NU-CHIPS5Northwestern University–Children’s
Perception of Speech; PPVT5Peabody Picture Vocabulary Test; WIPI5Word Intelligibility by Picture Identification; WJOC5Woodcock Johnson Oral Compre-
hension; WJPC5Woodcock Johnson Passage Comprehension WJUD5Woodcock Johnson Understanding Directions.
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that if an EVA occurs in isolation, the post–cochlear
implant hearing outcomes should be similar to those of a
child with normal temporal bone anatomy.16 However,
EVA occurs concomitantly with other cochleovestibular
anomalies in at least 40% of cases.10,31 The purpose of
this study was to characterize both speech perception
and speech/language measures within this group follow-
ing CI.
An anatomical approach to EVA classification
remains among the oldest and most popular.10 The
established classification of cochleovestibular malforma-
tion detailed by Sennaroglu and Saatci23 was used to
group our children into IEVA, IP 2 (classic Mondini
deformity), and IP 1 categories. Isolated EVA and IP 2
are considered mild to moderate, whereas IP 1 is consid-
ered a severe deformity. Our study explored all children
with the EVA who received CI, but did not include
defects occurring in the absence of an enlarged vestibu-
lar aqueduct. The findings appear consistent with pub-
lished results from others, as only a minority had severe
temporal bone defects.15
As a measure of residual hearing, the PTA in the
better hearing ear was identified. Over a quarter of the
patients in our cohort received CI with only severe hear-
ing loss. These children were distributed across the
duration of the study, though we noted a measurable
increase in the number of children with severe losses
and a decrease in the number of children with profound
losses who received CI in the latter decades. Ninety-five
percent of children implanted during the first decade
had profound hearing loss, 62.5% in the second decade,
and 60% thus far in the third decade. These findings are
likely due to growing awareness that children with EVA
are placed at a disadvantage when CI surgery is delayed
until profound hearing loss occurs, combined with an
increased awareness over time of the improved hearing
provided by CI. Accordingly, our model supports this,
and demonstrated at 1- to 13.5-point improved perform-
ance in children implanted with severe compared to pro-
found hearing loss. Statistical significance was present
only in one speech perception and two speech and lan-
guage tests, but this likely reflects our small sample
size. This finding can be further evaluated once addi-
tional children with EVA receive an implant sooner—
when an implant is provided prior to the hearing loss
reaching a profound level.
The mean age at implant in this study was just
over 6 years of age (73.4 months), well within what is
reported in the literature.2,18,22,31–34 This varied consid-
erably based on defect type. Children with IEVA were
substantially older at the time of implantation than
their peers, who presented with EVA combined with
other inner ear structural defects (112.8 months vs. 58.4
months, P<.001). Such findings are not surprising, as
one would expect more complex abnormalities to posi-
tively correlate with progressive hearing loss. In review-
ing the literature, no large study reporting that the EVA
anomaly affected age of implantation could be identified.
Lee et al. suggested more severe hearing impairment
secondary to development defects as a partial explana-
tion for the inferior performance of children with
additional anomalies accompanying the EVA on postim-
plant PTA testing.32 In their published series of 23
patients with EVA, they reported concomitant temporal
bone anomalies in 12 (52%) of their patients. Their
mean age of implantation was 5.3 years, but they did
not compare the age at implant for the two groups.
The greatest period of speech perception improve-
ment in our cohort occurred within the first 12 months
following implantation. Though both groups experienced
meaningful postimplantation gains, children with IEVA
tended to demonstrate stronger speech perception skills
prior to and following CI than their IP 2 counterparts.
We attribute this to the superior language skills this
group had prior to implantation. In our study, implanta-
tion enabled nearly all children to improve their speech
and language skills over time, with many obtaining
scores comparable to children with normal hearing.
Speech and language evaluations should therefore be
carefully followed overtime, and strongly considered in
determining when intervention with a cochlear implant
should occur.
Limitations
The retrospective nature of this study limited the
completeness of the data available. We could not report
on onset or duration of deafness in this group. It is quite
feasible that a child with rapidly progressive hearing
loss adapts differently than a child who experiences a
fluctuating or slowly deteriorating decline in hearing.
We also could not investigate the age at which initial
amplification was provided or the effects of sequential or
bilateral implantation in this population. To date, a total
of nine children have received bilateral implants, war-
ranting further investigation of this phenomenon when
this group of children is larger. The inability of younger
subjects to perform certain tests requires the adminis-
tration of different test batteries based upon the age and
language skills of the child (often varying in the 24-
month span covered by this study). This factor hindered
our ability to conclusively evaluate postimplantation
speech and language outcomes related to the degree of
residual hearing. The paucity of such data in the pub-
lished literature on this topic makes it apparent that
longitudinal data are difficult to acquire despite robust
efforts to ensure regular patient follow-up. Given the
substantial time span of this study, we did encounter
constraints due to changes in technology. Archived radio-
graphic images obtained prior to 2000 were sometimes
unavailable.
Over time, several variables have emerged as pre-
dictors of language achievement after CI, including age
at implantation, shorter periods of hearing loss, greater
residual hearing at the time of surgery, higher ratings of
parent-child interactions, higher socioeconomic status,
communication method, presence of additional disabil-
ities, and multilingualism.35 Language development is
complex, and the measureable benefit of interventions is
known to be quite variable. Ganek et al36 cautioned that
the wide variability in language outcomes and large
standard deviations limit the ability to construct an
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average implant recipient. This is especially true when
investigating outcomes in children with dysmorphic tem-
poral bones. Despite these limitations, we believe the
classification of pediatric CI recipients as performed in
this study adds meaningfully to the existing literature.
CONCLUSION
It has previously been established that the rate of
speech perception progression and the maximal open-set
response achieved with the use of cochlear implants are
related to the severity of the inner ear malformation.16,18
The current study indicates this is also the case when
treating children with enlarged vestibular aqueducts.
On average, children with isolated EVA have aided hear-
ing benefit for a longer period of time prior to implanta-
tion than their IP 2 counterparts. Both groups respond
very favorably to CI, though there does appear to be a
performance advantage for children with isolated EVA.
The challenge of producing long-term data for speech
perception outcomes persists. Accrual of data with the
intent to increase our understanding of the relationship
between recovered hearing and ongoing linguistic devel-
opment should continue.
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